Logo image
Impact of age on markers of HIV-1 disease
Journal article   Open access   Peer reviewed

Impact of age on markers of HIV-1 disease

Vanessa Pirrone, David J Libon, Christian Sell, Chad A Lerner, Michael R Nonnemacher and Brian Wigdahl
Future virology, v 8(1), pp 81-101
Jan 2013
PMID: 23596462
url
https://doi.org/10.2217/fvl.12.127View
Published, Version of Record (VoR) Open

Abstract

HIV-1 aging disease progression comorbidities neurocognitive impairment
Aging is a complicated process characterized by a progressive loss of homeostasis, which results in an increased vulnerability to multiple diseases. HIV-1-infected patients demonstrate a premature aging phenotype and develop certain age-related diseases earlier in their lifespan than what is seen in the general population. Age-related comorbidities may include the development of bone disease, metabolic disorders, neurologic impairment and immunosenescence. Age also appears to have an effect on traditional markers of HIV-1 disease progression, including CD4 + T-cell count and viral load. These effects are not only a consequence of HIV-1 infection, but in many cases, are also linked to antiretroviral therapy. This review summarizes the complex interplay between HIV-1 infection and aging, and the impact that aging has on markers of HIV-1 disease.

Metrics

6 Record Views
18 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Virology
Logo image